Call 800 665 0411 to learn about our services for your stock

Search   Follow Investorideas on Twitter   Investorideas is on Facebook   Investorideas is on Youtube   Investorideas is on Pinterest  Investorideas is on stocktwits   Investorideas is on tumblr   Investorideas is on LinkedIn   Investorideas Instagram   Investorideas Telegram   Investorideas Gettr   Investorideas RSS

Share on StockTwits

Canada's Legal Cannabis Industry Provides an Excellent Opportunity for Investment


December 17, 2019 ( Newswire) The legal cannabis market in Canada has attracted over $1 billion in venture capital in 2019. This new market is growing exponentially, leading to plenty of opportunities for private placement investing. VC funding for the Canadian cannabis industry exceeded its 2018 numbers by May 2019. Some of the prime opportunities for investment in the market are companies dedicated to growing and distribution. Let's take a quick look at some cannabis companies expected to grow exponentially over the next five years.

Canopy Growth

Chuck Rifici is often called the "godfather of Canadian weed" for his involvement in the industry. Canopy Growth was one of the first companies licensed to produce and sell medical products. It is now the world's largest marijuana company thanks to an initial $100K investment. Rifici focuses mainly on Canadian licensed producers, but he is shifting some focus to product-based companies. Now that marijuana has been legalized, branding opportunities for consumer products will be the next battleground. Consumers have no brand expectations and so carving out a niche with brand names can be a significant growth opportunity for young companies.


Greenway is one of the largest marijuana growers in Canada. The company has plans to operate 2,276,000 square feet of greenhouse facilities operated by professional growers. One unique aspect of Greenway is its dedication to seed genetics. Greenway has 92 seed varieties in its proprietary seed bank. The company has also started a process to genetically map its seed bank to help develop the best strains for market and production. Greenway has already conducted one round of non-brokered private placement funding for up to 2 million shares. That private placement offering happened in August 2018. Now the company is seeking another opportunity to sell 7 million shares for $0.75 CDN.

Aurora Cannabis

Aurora Cannabis is one of the largest marijuana companies in Canada. The company has conducted several funding rounds, with a private placement opportunity announced in January 2019. Aurora is a highly diversified Canadian marijuana cultivator, distributor, and innovator. Out of all licensed Canadian producers, Aurora has the highest production capacity potential. It also has the broadest international appeal among Canadian marijuana companies. With Global cannabis sales expected to rise to $200 billion by 2030, Aurora Cannabis is worth a look.

TerrAscend Corp.

TerrAscend focuses on products with cannabinoids in both the U.S. and Canada. It is also the first and only marijuana company to have sales in the U.S., Canada, and Europe. It has received EU GMP certification for its facility in Mississauga, ON. TerrAscend operates The Apothecarium, a cannabis dispensary chain with several locations in California and Nevada. The company also operates several sub-brands throughout Canada and the United States. Those brands include Arise Bioscience, Ilera Healthcare, Ascendant Laboratories, Solace RX Inc., and Valhalla Confections.

TerrAscend's presence in both Canada and the United States makes it a prime investment opportunity. Its brand catalog features several well-known cannabis brands in Canada and the United States. Offering branded products and running dispensary storefronts means TerrAscend's presence in the industry is very diversified.

Disclaimer/Disclosure: is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: This article is paid for published third party content and not the content of . Learn more about posting your articles at

Please read privacy policy: